Detalhe da pesquisa
1.
Association Between Immune-related Adverse Events and Efficacy of Immune Checkpoint Inhibitors in Non-small-cell Lung Cancer.
Clin Lung Cancer
; 20(3): 201-207, 2019 05.
Artigo
Inglês
| MEDLINE | ID: mdl-30442524